← All trials
NCT05283954
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2022
- Primary completion
- Jun 30, 2022
- Completion date
- Jul 30, 2022
- First posted
- Mar 17, 2022
- Last posted
- Mar 17, 2022
- Enrollment
- 954
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Lihir Medical CentreLead sponsor
- Lihir Medical CentreSponsor investigator
- Government of Papua New GuineaCollaborator
- FUNDACIÓN FLS DE LUCHA CONTRA EL SIDA, LAS ENFERMEDADES INFECCIOSAS Y LA PROMOCIÓN DE LA SALUD Y LA CIENCIACollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.